Trevi Therapeutics, Inc. (NASDAQ:TRVI) Short Interest Down 27.6% in April
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Rating) was the target of a large decline in short ...
Read moreTrevi Therapeutics, Inc. (NASDAQ:TRVI – Get Rating) was the target of a large decline in short ...
Read moreA rating of 100 puts Trevi Therapeutics Inc (TRVI) near the top of the Biotechnology industry ...
Read more© 2022 TheDailyStock.News